In the News: Judge Approves $22M for End-Payer Attorneys in Provigil Litigation
In the News: Judge Approves $22M for End-Payer Attorneys in Provigil Litigation The federal judge overseeing the Provigil antitrust litigation has awarded attorneys representing end-payers nearly $22 million in fees. U.S. District Judge Mitchell Goldberg of the Eastern District of Pennsylvania on Tuesday awarded $21.9 million to leading attorneys representing the group of consumers […]
In the News: Judge Approves $22M for End-Payer Attorneys in Provigil Litigation Read More »